BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

XClinical GmbH Expands its Services to the United States


3/10/2008 11:25:38 AM

MUNICH, Germany--(BUSINESS WIRE)--XClinical, a European vendor of innovative software products for e-clinical trials, today reported that BioStat International Inc. (BSI), a contract research organization (CRO) headquartered in Tampa, FL, USA, will soon begin a very unique medical device study. BSI was trained at the end of October 2007 on behalf of a global industry leader. The comprehensive training session on MARVIN, XClinical’s innovative EDC system, empowered the CRO in less than 12 weeks to set-up the clinical trial independently without the assistance of XClinical’s technical personnel. The ability to become independent in design and implementation of a clinical trial in a very short time period was an important reason for choosing MARVIN. Specific functionalities that were important in the selection of MARVIN in addition to traditional electronic data capture included “Patients as Users” to directly collect Patient Reported Outcome as part of the trial design, “Double Data Entry” capability which allows the conduct of hybrid studies through simultaneous EDC and DDE, and, finally, integration of binary data collected via the diagnostic measuring devices used in the study. XClinical will also be responsible for hosting services and managing the data transfer from the measuring devices to the study database.

Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES